A First-in-Human Phase I Monotherapy Study of RG7212 (R), a Novel Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Solid Tumors Proffered Paper Session
Antiretroviral therapy for the prevention of HIV: where are we now and where are we going? Special Plenary Session
Initial Results from the SAPHIRE Study: a Phase II Trial with the Novel Oral Histone Deacetylase (HDAC) Inhibitor Resminostat in Relapsed or Refractory Hodgkin Lymphoma Patients New Drugs
Extended Follow-Up of the Safety of 131I Radiolabelled Anti-CD25 Antibody, Basiliximab, in Patients with CD25-Positive, Refractory Hodgkin Lymphoma New Drugs
Modern cancer drugs - will they be affordable in the future? Cancer Prevention and Health Politics: Economical and other Controversies
Severe hypoalbuminemia in a patient with long duration Crohn's disease treated with Infliximab Challenging Cases
Long- term outcome of treatment with infliximab in paediatric Crohn's disease : a population-based study Safety in IBD therapy
Deep remission for adalimumab-treated patients with moderate to severe ileocolonic Crohn’s disease: Results from EXTEND It's not always IBD
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis Extraintestinal manifestations